Safety and Effectiveness of Corneal Crosslinking (CXL): Keratoconus and Post-Refractive Ectasia

NCT03080077 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Keratoconus
Ectasia

Interventions

DRUG: Ricrolin+
DRUG: Epi-Off

Sponsor

Icahn School of Medicine at Mount Sinai